Richard L. Lindstrom MD, a director at Ocular Therapeutix Inc. ($OCUL), made two open market purchases of common shares totaling about $531,000 over the past year. His most recent buy occurred on February 20, 2026. These purchases rank 780th among 4,983 individual insiders by dollar amount, below the average of $1.5 million across 3.29 transactions. Lindstrom reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | P | Common Stock | 60229 | $7.66 | 246,933.0000 | 187,241,483 | 32.26% | 0.03% |
| June 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 169,396,989 | 9999.99% | 0.03% |
| June 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | A | Common Stock | 14000 | $0.00 | 186,704.0000 | 169,396,989 | 8.11% | 0.01% |
| May 23, 2025 | LENSAR, Inc. | $LNSR | LINDSTROM RICHARD L MD | Not found | A | Common Stock | 7374 | $0.00 | 246,410.0000 | 11,518,000 | 3.08% | 0.06% |
| May 8, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | P | Common Stock | 10000 | $6.96 | 172,704.0000 | 169,396,989 | 6.15% | 0.01% |
| July 24, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | A | Common Stock | 12000 | $0.00 | 162,704.0000 | 165,824,778 | 7.96% | 0.01% |
| Feb. 27, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | M | Stock Option (Right to Buy) | 18939 | $0.00 | 0.0000 | 85,596,594 | 100.00% | 0.02% |
| Feb. 27, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | M | Stock Option (Right to Buy) | 11363 | $0.00 | 0.0000 | 85,596,594 | 100.00% | 0.01% |
| Feb. 27, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | M | Common Stock | 18939 | $8.80 | 139,341.0000 | 85,596,594 | 15.73% | 0.02% |
| July 24, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | A | Stock Option (Right to Buy) | 36000 | $0.00 | 36,000.0000 | 165,824,778 | 9999.99% | 0.02% |
| Feb. 27, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | LINDSTROM RICHARD L MD | Director | M | Common Stock | 11363 | $8.80 | 150,704.0000 | 85,596,594 | 8.15% | 0.01% |
| May 7, 2024 | LENSAR, Inc. | $LNSR | LINDSTROM RICHARD L MD | Not found | A | Common Stock | 22000 | $0.00 | 239,036.0000 | 10,971,000 | 10.14% | 0.20% |
| May 25, 2023 | LENSAR, Inc. | $LNSR | LINDSTROM RICHARD L MD | Director | A | Common Stock | 9288 | $0.00 | 217,036.0000 | 0 | 4.47% | 0.00% |
| May 25, 2023 | LENSAR, Inc. | $LNSR | LINDSTROM RICHARD L MD | Director | A | Stock Option (Right to Buy) | 33175 | $0.00 | 33,175.0000 | 0 | 9999.99% | 0.00% |